| |
|
|
Il-Yang Pharm. Co.,Ltd. (007570) |
|
|
STOCK |
|
|
|
  |
(unit : Won, Share) |
| Fiscal Year End |
07.03 | 08.03 | 09.03 | 09.09 |
| Par Value |
2,500 | 2,500 | 2,500 | 2,500 |
| Yearly Highest Price |
26,400 | 82,000 | 62,700 | 45,400 |
| Yearly Lowest Price |
14,000 | 25,300 | 8,460 | 27,000 |
| Common Shares O/S |
14,102,526 | 14,102,526 | 14,102,526 | 14,102,526 |
| Preferred Shares O/S |
445,080 | 445,080 | 445,080 | 445,080 |
| Market Cap.(100Mn.Won) |
3,727 | 7,733 | 4,425 | 4,735 |
| Dividends (%) |
5.0 | 4.0 | - | - |
|
 |
(Company/Sector/Market) |
| |
2008.06 | 2009.06 |
| Beta |
1.16 / 0.68 / 1.00 | 1.14 / 0.54 / 1.00 |
| Volatility |
60.31 / 23.43 / 26.01 | 96.61 / 32.47 / 41.28 |
|
 |
(unit : Won) |
| Fiscal Year End |
07.03 | 08.03 | 09.03 | 09.09 |
| Earnings Per Share |
238 | 72 | - 1,216 | 26 |
| Sales Per Share |
9,829 | 8,843 | 8,385 | 9,885 |
| Book Value Per Share |
4,829 | 5,018 | 7,680 | 7,725 |
| Cash Flow Per Share |
436.96 | - 222.78 | - 123.39 | - 912.00 |
|
 |
(Unit : Times) |
| Fiscal Year End |
07.03 | 08.03 | 09.03 | 09.09 |
| Price / Earnings (H/L) |
110.92/58.82 | 1,138.89/351.39 | -/- | 1,746.15/1,038.46 |
| Price / Sales (H/L) |
2.69/1.42 | 9.27/2.86 | 7.48/1.01 | 4.59/2.73 |
| Price / Book (H/L) |
5.47/2.90 | 16.34/5.04 | 8.16/1.10 | 5.88/3.49 |
| Price / Cash Flow (H/L) |
60.42 / 32.04 | - /- | - /- | - /- |
|
 |
(Unit : 100Mn.Won, %) |
| Fiscal Year End |
06.03 |
07.03 |
08.03 |
09.03 |
| Company |
Sector |
Company |
Sector |
Company |
Sector |
Company |
Sector |
| Invested Capital |
1,118 |
714 |
1,192 |
708 |
1,295 |
942 |
1,857 |
- |
| NOPLAT |
18 |
54 |
45 |
60 |
6 |
71 |
- 110 |
- |
| Return on Invested Capital |
1 |
7 |
3 |
8 |
0 |
7 |
- 5 |
- |
| WACC |
6 |
6 |
6 |
6 |
8 |
6 |
8 |
- |
| Economic Value Added |
- 57.8 |
8.6 |
- 32.5 |
10.9 |
- 100.3 |
5.3 |
- 267.6 |
- |
|
 |
(Unit : 100Mn.Won, Times) |
| Fiscal Year End |
2007.03 | 2008.03 | 2009.03 | 2009.09 |
| Enterprise Value(EV) |
4,142.77 | 8,256.11 | 5,177.68 | 5,561.99 |
| EBITDA |
90.06 | 32.40 | - 88.23 | 62.15 |
| EBITDA/Sales |
0.07 | 0.03 | - 0.08 | 0.05 |
| EBITDA/Financial Exp. |
3.06 | 0.93 | - 1.43 | 1.24 |
| EV/EBITDA |
46.00 | 254.81 | - | 89.50 |
|
|
|
|
